Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (441-450 of 661) with videos related to

Pageof 67
Sort By:
Frontiers in Nutrition|April 21, 2022
Transformation Mechanism of Rare Ginsenosides in American Ginseng by Different Processing Methods and Antitumour EffectsZhi-Man Li, Zi-Jun Shao, Di Qu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2024
Entrectinib versus crizotinib in Asian patients with ROS1-positive non-small cell lung cancer: A matching-adjusted indirect comparisonYongfeng Yu, Yun Fan, Xiaorong Dong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2024
Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical TrialZhiwei Chen, Lin Wu, Qiming Wang, et al.
Nature Microbiology|March 10, 2026
A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in miceHaiyan Zhou, Ruiming Sun, Xiaoqun Nie, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|September 4, 2009
Correlation of the SNPs of FGFR1, FGF10, FGF18 with nonsyndromic cleft lip with or without palate in Chinese populationWei-dong Wan, Shun-lu Yang, Jia-yin Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 16, 2024
IMpower210: A phase III study of second-line atezolizumab <i>vs.</i> docetaxel in East Asian patients with non-small cell lung cancerYi-Long Wu, Shun Lu, Gongyan Chen, et al.
Therapeutic Advances in Medical Oncology|September 1, 2023
Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced <i>RET</i> fusion-positive non-small-cell lung cancer and thyroid cancer, and <i>RET</i>-mutant medullary thyroid cancer in the phase II LIBRETTO-321 trialShun Lu, Xiangqian Zheng, Yuping Sun, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 21, 2009
Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancerXiao Yao, Hua Jiang, Cuizhen Zhang, et al.
Human Pathology|December 17, 2009
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomasRobert F Luo, Shuchun Zhao, Robert Tibshirani, et al.
Ecotoxicology and Environmental Safety|January 30, 2022
Integrated metabolomics and transcriptomics analysis reveals new biomarkers and mechanistic insights on atrazine exposures in MCF‑7 cellsYu-Shun Lu, Shang-Lin Yang, Chun-Lin Gou, et al.
Pageof 67

Showing results (441-450 of 661) with videos related to

Sort By:
Pageof 67
Frontiers in Nutrition|April 21, 2022
Transformation Mechanism of Rare Ginsenosides in American Ginseng by Different Processing Methods and Antitumour EffectsZhi-Man Li, Zi-Jun Shao, Di Qu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2024
Entrectinib versus crizotinib in Asian patients with ROS1-positive non-small cell lung cancer: A matching-adjusted indirect comparisonYongfeng Yu, Yun Fan, Xiaorong Dong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2024
Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical TrialZhiwei Chen, Lin Wu, Qiming Wang, et al.
Nature Microbiology|March 10, 2026
A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in miceHaiyan Zhou, Ruiming Sun, Xiaoqun Nie, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|September 4, 2009
Correlation of the SNPs of FGFR1, FGF10, FGF18 with nonsyndromic cleft lip with or without palate in Chinese populationWei-dong Wan, Shun-lu Yang, Jia-yin Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 16, 2024
IMpower210: A phase III study of second-line atezolizumab <i>vs.</i> docetaxel in East Asian patients with non-small cell lung cancerYi-Long Wu, Shun Lu, Gongyan Chen, et al.
Therapeutic Advances in Medical Oncology|September 1, 2023
Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced <i>RET</i> fusion-positive non-small-cell lung cancer and thyroid cancer, and <i>RET</i>-mutant medullary thyroid cancer in the phase II LIBRETTO-321 trialShun Lu, Xiangqian Zheng, Yuping Sun, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 21, 2009
Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancerXiao Yao, Hua Jiang, Cuizhen Zhang, et al.
Human Pathology|December 17, 2009
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomasRobert F Luo, Shuchun Zhao, Robert Tibshirani, et al.
Ecotoxicology and Environmental Safety|January 30, 2022
Integrated metabolomics and transcriptomics analysis reveals new biomarkers and mechanistic insights on atrazine exposures in MCF‑7 cellsYu-Shun Lu, Shang-Lin Yang, Chun-Lin Gou, et al.
Pageof 67